Clinical Scorecard: Vitamin D May Aid Hearing Recovery in Pilot Trial
At a Glance
| Category | Detail |
|---|---|
| Condition | Sudden Sensorineural Hearing Loss |
| Key Mechanisms | Vitamin D supplementation may enhance hearing recovery when combined with corticosteroids. |
| Target Population | Patients with unilateral sudden sensorineural hearing loss and vitamin D deficiency. |
| Care Setting | Single-center, double-blind clinical trial. |
Key Highlights
- Vitamin D3 (50,000 IU) added to corticosteroids showed improved hearing at 2000 Hz and 4000 Hz.
- No significant advantage of vitamin D at lower frequencies (500 Hz, 1000 Hz) or 6000 Hz.
- Both treatment and control groups showed overall hearing improvement over 30 days.
- Vitamin D levels increased significantly in the treatment group.
- No adverse events reported during the trial.
Guideline-Based Recommendations
Diagnosis
- Assess serum vitamin D levels in patients with sudden sensorineural hearing loss.
Management
- Consider vitamin D supplementation alongside corticosteroid therapy for eligible patients.
Monitoring & Follow-up
- Audiometric testing at baseline, day 10, and day 30 to evaluate hearing recovery.
Risks
- Limited by small sample size and short follow-up; further studies needed.
Patient & Prescribing Data
Patients with unilateral sudden sensorineural hearing loss of 45 days or less and vitamin D deficiency.
Weekly vitamin D3 supplementation may provide additional benefits in hearing recovery.
Clinical Best Practices
- Utilize block randomization and maintain blinding in clinical trials.
- Employ nonparametric statistical methods for non-normally distributed data.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
